Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in Egypt / NCT06976164
Recruiting Not applicable

Reflexo Therapy for Gestational Diabetes Mellitus

NCT06976164 · tracked via the Priya Life Science Egypt tracker
Sponsor
Kafrelsheikh University
Phase
Not applicable
Started
2025-05-01
Last updated
2025-05-16

Condition(s) studied

Physical Therapy

Investigational drug(s) / intervention(s)

The standard antenatal care.Foot reflexology.

The standard antenatal care.: Antenatal Protocol.

Foot reflexology.: A manual therapy technique.

Study summary

The purpose of this study will be to detect the effects of Reflexo therapy of sole on GDM.

Eligibility

Sex
FEMALE
Min age
20 Years
Max age
35 Years
Healthy volunteers
No
Inclusion Criteria: 1. They were maternally aged between 20 and 35 years. 2. The gestational age ranged from between 24 and 36 weeks. 3. Their BMI didn't exceed 30 kg/m2. 4. A singleton live fetus and not under stressful event. Exclusion Criteria 1. They had high-risk pregnancies. 2. Bad obstetric situations. 3. Diseases that could interfere with participation. 4. Smoking. 5. Oral sedative administration.

Primary outcome measure(s)

  • Change in The Oral Glucose Tolerance Test. — Change from Baseline Oral Glucose Tolerance Test at one month
  • Change in The Hemoglobin A1C Test. — Change from Baseline Hemoglobin A1C Test at one month

Trial sites (2)

FacilityCityRegionStatus
The Outpatient Clinics, Faculty of Physical Therapy Kafrelsheikh University. Cairo Egypt Recruiting
The Outpatient Clinics, Faculty of Physical Therapy Kafrelsheikh University. Cairo Egypt Recruiting

More Kafrelsheikh University trials in Egypt

Effect of Task Specific Electrical Stimulation on Upper Limb Gross Motor Skills in Children With Spastic Quadriplegia Recruiting
Affection of Symptoms Duration on Outcomes of Lumbar Spine Surgery Recruiting
Bone Cement Augmented Transpedicular Screw Fixation Versus Cannulated Screws Fixation in Osteoporotic Spine Recruiting
Evaluation of Internal Nasal Splint-Supported Free Graft Versus Nasoseptal Flap for Endoscopic Skull Base Repair in Cerebrospinal Fluid Leaks Recruiting
No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06976164 on ClinicalTrials.gov ↗ ← All trials in Egypt